We have characterized the lipid rafts in myelin from a spontaneously demyelinating mouse line (ND4), and from control mice (CD1 background), as a function of age and severity of disease. Myelin was isolated from the brains of CD1 and ND4 mice at various ages, and cold lysed with 1.5% CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulphonate). The lysate was separated by low-speed centrifugation into supernatant and pellet fractions, which were characterized by Western blotting for myelin basic protein (MBP) isoforms and their post-translationally modified variants. We found that, with maturation and with disease progression, there was a specific redistribution of the 14-21.5 kDa MBP isoforms (classic exon-II-containing vs exon-II-lacking) and phosphorylated forms into the supernatant and pellet. Further fractionation of the supernatant to yield detergent-resistant membranes (DRMs), representing coalesced lipid rafts, showed these to be highly enriched in exon-II-lacking MBP isoforms, and deficient in methylated MBP variants, in mice of both genotypes. The DRMs from the ND4 mice appeared to be enriched in MBP phosphorylated by MAP kinase at Thr95 (murine 18.5 kDa numbering). These studies indicate that different splice isoforms and post-translationally modified charge variants of MBP are targeted to different microdomains in the myelin membrane, implying multifunctionality of this protein family in myelin maintenance.
Introduction
. Thus, it appears that MBP is more than just a ''membrane Velcro''; it may serve as another point of intersection in phosphorylationand calmodulin-mediated signal transduction pathways controlling local cytoskeletal architecture in oligodendrocytes (Dyer 2002; Campagnoni and Campagnoni 2004; Harauz et al. 2004; Boggs 2006) .
Membrane (lipid) rafts and microdomains in myelin
Lipid rafts form a large class of glycosphingolipid and cholesterol enriched microdomains in the membranes of all mammalian cell types, and are implicated in secretion, endocytosis, cell surface proteolysis, and signalling, including initiation of MAP kinase cascades (Simons and Ikonen 1997; Zajchowski and Robbins 2002; Simons and Ehehalt 2002; Quest et al. 2004; Golub et al. 2004; Rajendran and Simons 2005; Hancock 2006) . Differential cold-detergent extractions of plasma membranes and whole cells yield detergent-resistant membranes (DRMs), which represent coalesced membrane lipid rafts. Under some conditions, though, DRMs may also comprise other membrane microdomains (Lichtenberg et al. 2005; Hancock 2006) . A consensus definition of lipid rafts has recently been published (Pike 2006) : ''Membrane rafts are small (10-200 nm), heterogeneous, highly dynamic sterol-and sphingolipid-enriched domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.' ' We have recently investigated the association of MBP with the lipid rafts of mature and developing bovine CNS myelin (DeBruin et al. 2005) . Myelin and early myelin-like membranes were extracted with cold detergent (CHAPS, dimethylammonio]-1-propanesulphonate) and separated on a sucrose density gradient yielding DRMs ( Fig. 1) (DeBruin et al. 2005) . We found that DRMs from early developing myelin, which had little or no GalC or sulphatide (the raft lipids sphingomyelin and cholesterol were present, however), were enriched in Src tyrosine kinases, Golli-MBP isoforms, and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP). In mature myelin, the DRMs no longer contained Src kinases or Golli-MBP, but were enriched in phosphoThr-MBP (the MAP kinase phosphorylated form), CNP, PLP (proteolipid protein), MAG (myelin-associated glycoprotein), and MOG (myelin-oligodendrocyte glycoprotein), along with GalC and sulphatide. These myelin rafts were disrupted when cholesterol was depleted with methylb-cyclodextrin. Our results were consistent with Src kinases, Golli-MBP isoforms, and CNP, being important signalling proteins in early myelin development (Gravel et al. 1996; Krämer et al. 1999; Givogri et al. 2001; Jacobs et al. 2005; Lee et al. 2005) . The finding that phosphoThr-MBP was localized in the DRMs of mature myelin suggested that this form of the protein has specific functions requiring this localization.
We hypothesize that MBP is a multifunctional protein (Harauz et al. 2004; Boggs 2006) and that in healthy myelin, specific post-translational modifications of MBP target it to distinct membrane microdomains in a developmentally regulated manner: phosphoThr-MBP is translocated into lipid rafts in myelin, whereas deiminated and methylated MBP are excluded from these microdomains (DeBruin et al.
2005
). In myelin rafts, classic MBP isoforms may facilitate the relay of signals from the plasma membrane to the cell interior (Dyer 2002; Campagnoni and Campagnoni 2004; Boggs et al. 2004; Boggs 2006) , potentially by modulating the underlying physicochemical properties of the membrane (Harauz et al. 2004; Maggio et al. 2005) , and the degree of assembly of the underlying cytoskeleton (Wilson and Brophy 1989; Boggs et al. 2005; . In the demyelinating state, as occurs in MS, MBP is more citrullinated and less phosphorylated overall (Kim et al. 2003; Mastronardi and Moscarello 2005) ; thus, the modified charge components of MBP are either not targetted to their specific microdomain, or their degree of modification and function in the microdomain is changed DeBruin and Harauz 2006) . Thus, cellular processes, such as signalling events within lipid rafts and other microdomains, would be altered, which may have an impact on attempts at remyelination.
Here we have applied our myelin membrane fractionation techniques to study the dynamic translocation of MBP into myelin microdomains (lipid rafts) during active demyelination. We have used a spontaneously demyelinating ND4 transgenic mouse line with 70 copies of the PLP variant DM20, under the control of the normal PLP promoter, incorporated into their genome (Mastronardi et al. 1993; Johnson et al. 1995) . This mouse line serves as a model for some forms of MS, as a result of the altered patterns of post-translational modifications of MBP (Mastronardi et al. 1996a (Mastronardi et al. , 1996c Barrese et al. 1998) . The goals of this present study were to characterize the partitioning of MBP into membrane microdomains during ageing and active demyelination, which will further define the role of altered MBP in signalling pathways during myelin development and maintenance, and provide new insights into the mechanisms of myelin destabilization in diseases such as MS.
Materials and methods

ND4 transgenic mice
We established an ND4 transgenic mouse colony at the Central Animal Facility of the University of Guelph (Guelph, Ontario), after approval of a detailed animal utilization protocol (No. 03G014) according to University guidelines. Breeding pairs were obtained from Dr. Mario Moscarello (Hospital for Sick Children, Toronto, Ontario), and a pathogen-free line was derived via embryo transfer performed at the Ontario Cancer Institute (Toronto, Ontario). Our colony was maintained in a controlled and environmentally enriched environment. The ND4 mice are heterozygous, so their normal littermates (the CD1 background) serve as controls. The mice were determined to carry the DM20 transgene by PCR analysis of DNA isolated from tail clips obtained upon weaning. The b-globin gene was amplified as a control. All mice (ND4 and CD1 littermates) were weighed and scored for clinical signs each week.
Neurological abnormalities
A clinical score was assigned for several signs for each animal during weekly examinations. The scores ranged from 0 (absent) to 5 (severe) for the following clinical features: rough coat (0 or 1), dragging tail (0, 1, or 2), whole body tremors (0, 2, or 4), hindleg weakness or wobbly gait (0, 2, or 3), and tonic seizures (0, 4, or 5 ). An average clinical score was calculated from all observations at each age, which ranged from 10 to 20. The cohort of control and transgenic mice was followed for approximately 13 months.
Histopathology of brain tissue
Histopathological analyses were performed as follows. Mice (ND4 and age-matched CD1 controls) were sacrificed by CO 2 asphyxiation. Brains were immediately removed and fixed in 10% buffered formalin for 48 h, and then tissues were embedded in paraffin and sectioned at 5 mm thicknesses. Sections were stained with hematoxylin-eosin (HE) and Luxol Fast Blue (LFB). Brain samples from CD1 and ND4 mice at the ages of 7 months (the beginning of observable clinical signs) and 10.3 months (clinical signs included tonic seizures at this age) were examined.
Isolation of DRMs
The initial characterization of myelin membrane microdomains in spontaneously demyelinating (ND4) and control mice (CD1) was investigated through CHAPS detergent treatment (DeBruin et al. 2005) , as schematized in Fig. 1 . For biochemical analyses, mice were sacrificed by cervical dislocation, and whole brains were flash frozen in liquid ni- Fig. 1 . Scheme for the isolation of CHAPS detergent resistant membranes (DRMs) from CNS myelin. Myelin from whole mouse brains was treated with 1.5% CHAPS on ice for 30 min. A lowspeed centrifugation step separated DRMs and solubilized lipids and proteins into the supernatant fraction, whereas the pellet fraction contained large myelin membrane fragments and subcellular organelles. The supernatant fraction was applied to a step sucrose density gradient and subjected to ultracentrifugation. The DRMs, which represented coalesced lipid rafts, were highly enriched in glycosphingolipids and cholesterol, and thus had a low buoyant density. The solubilized lipids and proteins were found in the last high-density fractions.
trogen. Myelin samples were isolated from 2-to 13 monthold mouse brains, males and females separately, using the method of Norton and Poduslo (Norton and Poduslo 1973; Quarles 1980 ). On ice, the myelin membranes (500 mg protein) were extracted with cold detergent (1.5% CHAPS at 4 8C) in 25 mmol/L Tris-HCl (pH 7.5), 140 mmol/L NaCl, and 2 mmol/L EDTA buffer supplemented with protease inhibitors. After the 30 min lysis period, the sample was centrifuged (10 000g, 4 8C, 10 min). The pellet (denoted P1 or P) was resuspended into the same volume as the supernatant (denoted S1 or S) in 10 mmol/L Tris-HCl (pH 8.0) buffer with 1% SDS for analysis.
The supernatant, containing DRMs and highly solubilized proteins and lipids, was adjusted to contain 40% sucrose and applied to a discontinuous sucrose density gradient (40%, 30%, and 5% steps). Samples were centrifuged in a VTi 65.2 rotor (Beckman Coulter, Fullerton, California) at 64 000 rpm (402 000g) for 3 h; 13 fractions were collected from the top of the tube by displacement. Fraction 1 (top) had the lowest sucrose concentration (5%) and fraction 13 the highest (40%).
The sucrose density gradient fractions (1-13), and the supernatant and pellet fractions ( Fig. 1) , were analyzed by SDS-PAGE and Western blotting for the presence of MBP and its modified forms, and for several other myelin-specific proteins, as previously described (DeBruin et al. 2005) . For distribution comparisons, equal volumes of the supernatant and pellet fractions were analyzed. Antibody-binding was detected by enhanced chemiluminescence (ECL, Amersham Biosciences, Baie d'Urfe, Québec), and band densities were quantified with AlphaEaseFC software (Alpha Inotech Corp., San Leandro, California).
The following antibodies used for Western blotting were generous gifts: polyclonal anti-MBP(E5) (Dr. Joan Boggs, Hospital for Sick Children, Toronto, Ontario), polyclonal anti-MAG (myelin-associated protein; Dr. Anthony Heape, University of Oulu, Finland), and polyclonal anti-exon-II-MBP (Dr. David Colman, McGill University, Montréal, Québec).
The following antibodies were purchased: monoclonal antiactin (clone C4, Chemicon; Temecula, California) monoclonal anti-arginine (mono-and di-methyl Ab412, Abcam; Cambridgeshire, UK), monoclonal anti-CNP (SMI 99, Sternberger; Lutherville, Maryland), monoclonal anti-phosphoThr98 MBP (clone 98P12, Serotec; Raleigh, North Carolina), and appropriate horseradish peroxidase (HRP)-conjugated secondary antibodies (Sigma-Aldrich, Oakville, Ontario).
Results
Neurological abnormalities
All mice (ND4 and CD1 littermates) were weighed and assessed for clinical signs each week; the data averaged over each month are presented in Fig. 2 . The ND4 mice, both male and female, were lighter in weight than their CD1 counterparts. Up to 6 months of age, mice did not display any abnormal behaviour or signs. Male ND4 mice displayed more severe clinical signs earlier than female ND4 mice. By 9 months of age, both male and female ND4 mice had higher clinical scores than their age-matched CD1 controls. Tonic seizures were typically observed in the transgenic mice after 10 months of age. Beyond 13 months, most transgenic animals displayed severe clinical signs that inhibited their ability to obtain food and water.
Histopathology of mouse brain tissue
Histopathological analyses were completed on brain samples from 4 CD1 and ND4 mice, including a male and female of each genotype, at the ages of 7 months (the beginning of observable clinical signs) and 10.3 months (clinical signs included tonic seizures at this age). No structural abnormalities were identified in any samples. At 7 months, demyelination was not detected. At 10.3 months, demyelination was pronounced in the ND4 brain (Fig. 3) , and from the sections analyzed, the male brain appeared to have a greater extent of demyelination.
Myelin microdomains (lipid rafts) during demyelination
The myelin microdomains in the spontaneously demyelinating (ND4) and control mice (CD1) were characterized at different ages, as described. The distribution pattern of the various proteins (MAG, CNP, actin, MBP, exII-MBP, and phosphoThr-MBP) between the supernatant and the pellet fraction after cold CHAPS lysis of myelin was similar for CD1 and ND4 mice (Figs. 4, 5) . In general, more MBP was found in the supernatant than in the pellet from younger mice (2.0 and 5.8 months), whereas in older mice (7.7 and 13 months) the distribution of MBP was about equal between the supernatant and the pellet fractions. A similar pattern was observed for phosphoThr-MBP. A unique pattern was seen for exII-MBP; in samples from younger mice, this form of the protein preferentially (*60%) partitioned into the pellet, and in samples from older mice, it preferentially (*70%) partitioned into the supernatant. The 20.2 kDa isoform of MBP is predominantly methylated, and was only found in the pellet fraction, regardless of age.
When we looked at the specific isoforms of classic MBP that were distributed into the supernatant and pellet, there were some changes with maturation and with disease progression, although differences between males and females were not observed (Fig. 4) . Approximately 15% of the 21.5 kDa isoform was found in the supernatant fraction from young mice. In old mice, all of this isoform remained in the pellet fraction. Regardless of age and genotype, the 20.2 kDa isoform was always found exclusively in the pellet fraction. Under the SDS-PAGE conditions employed, it was not possible to resolve the 17.22 kDa exon-II-containing isoform from the 17.24 kDa exon-II-lacking isoform. Approximately 45% of the 17.22-17.24 kDa isoforms was detected in the supernatant fraction from the myelin of young mice, whereas about 35% was in the supernatant of the older mice. The exon-II-lacking 18.5 and 14 kDa isoforms of MBP were distributed mainly into the supernatant. All of the isoforms had Thr95 (murine 18.5 kDa sequence numbering, human Thr98) phosphorylated, as detected by Western blotting with monoclonal anti-phosphoThr98 MBP antibody. In young mice, there was a modest increase in the phosphoThr-modified classic 18.5 kDa and 14 kDa isoforms (*28%) in the supernatant from ND4 mice, compared with CD1 mice. This increase in 18.5 kDa phosphoThr-MBP localization within the supernatant was slightly more pronounced (*34%) in the older ND4 mice displaying clinical signs.
Further characterization of the supernatant fractions was completed by sucrose density gradient separation, which yielded 13 equal volume fractions (Fig. 1) . The highly solubilized proteins and lipids were found at the bottom of the gradient (fractions 12 and 13). The DRMs, which were buoyant due to their lipid enrichment, floated to a lower density. With our step gradient, the DRMs were typically in fractions 4-6, as indicated by Western blotting and total protein assays (Figs. 6 and 7) .
From Western blots, MAG, CNP, and MBP were localized in DRM fractions in young and old mice of both geno- Fig. 3 . Histological assessment of the cerebella of CD1 and ND4 mice. The CD1 (control, negative) and ND4 (transgenic, positive) mice were sacrificed, and their brains were removed, fixed, embedded, sectioned, and stained with hematoxylin-eosin and Luxol Fast Blue. The CD1 mice (both male and female, each 10.3 months) had essentially normal myelin (bluish stain), as assessed at this level, whereas the ND4 mice (both male and female, each 10.3 months) had extensive vacuolation.
types (Fig. 6) . The 18.5, 17.2 (17.22 and (or) 17.24), and 14 kDa MBP isoforms were enriched in the DRMs. No phosphoThr-MBP was detected in any fractions from young CD1 mice, whereas in young ND4 mice, phosphoThr-MBP was detected only in the nonraft fractions (12 and 13). In the older mice of both genotypes, phosphoThr-MBP was localized in the nonraft fractions. PhosphoThr-MBP was easily detected in the DRM fractions of the ND4 mice, whereas only very low levels were detected from the CD1 mice. In both the younger and older CD1 mice, there were lower levels of the phosphorylated 18.5 kDa isoform in the supernatant fraction, which was applied to the sucrose density gradient; therefore, the detection of phosphoThr-MBP in the gradient fractions may have been near the sensitivity level of the detection system. However, since the electrophoresis and the Western blotting conditions were the same and conducted simultaneously for the CD1 and ND4 samples, the overall level of phosphoThr-MBP in DRMs was greater in the ND4 samples.
After silver staining the SDS -polyacrylamide gel of sucrose gradient fractions, differences were apparent between the DRMs of myelin from CD1 and ND4 mice (Fig. 7) . In general, DRMs isolated from the myelin of older mice had more protein bands in the 30-70 kDa range than those from younger mice. The DRMs from the ND4 mice contained more bands below 25 kDa than those from the CD1 mice. As shown above, MAG, CNP, and MBP were determined to be present by Western blotting.
Discussion
The ND4 transgenic mouse line as a model for demyelination
Multiple sclerosis is a complex human neurodegenerative disease of unknown origin, and is characterized by the active destruction of the insulating myelin sheath around the axons. The most common manifestation of the disease is chronic and relapse-remitting, in which the myelin sheath is Fig. 4 . Distribution of proteins into the supernatant and pellet fractions from a CHAPS lysis of mouse myelin: Western blotting. Comparison of the distribution of specific proteins in the supernatant and pellet fractions in young (2 months) and old (>8 months) CD1 and ND4 mice by SDS-PAGE on a 14% gel. Equal volumes of each fraction were analyzed by Western blotting for MAG, CNP, actin, and MBP (total MBP, exon-II-containing isoforms (exII-MBP), methylated MBP (m-MBP), and phosphoThr-MBP (p-MBP)). Antibody dilutions were as follows: anti-MAG (1:3000), anti-CNP (1:2000), anti-actin (1:4000), anti-MBP (1:2000), anti-exII-MBP (1:5000), anti-methyl-MBP (1:250), and anti-phosphoThr98 MBP (1:1000). In most blots for MBP and p-MBP, the 21.5 and 20.2 kDa isoforms could be resolved, but not the 17.22 or 17.24 kDa isoforms. The 18.5 and 14 kDa bands were always resolved from other isoforms. After probing for methylated MBP, the blot was stripped (Restore Western Blot Stripping Solution Buffer; Pierce, Rockford, Illinois), and reprobed for MBP; it was thus determined that the major methylated MBP component was the 20.2 kDa isoform. Molecular masses on the right hand side are indicated in kDa.
repaired to a certain extent to enable a moderate clinical remission (Lassmann et al. 2001; Lassmann 2004 ). Multiple sclerosis is unique to humans because of its complex aetiology, and any animal model is appropriate only to represent a particular facet or variant of the disease (Duncan et al. 1997; Dubois-Dalcq et al. 2005) . The most commonly used animal model for MS has been experimental allergic encephalomyelitis (EAE), in which demyelination via an autoimmune response is induced in a susceptible host by injection of a myelin component, such as MBP or MOG (Makhlouf et al. 2002) . Almost all therapies for human MS have been based on EAE studies and the premise that MS is an autoimmune disease, but this assumption has severe limitations Behan 2004, 2005; Sriram and Steiner 2005) . The reason is the heterogeneity of MS: there appear to be 4 major types of lesions (Lucchinetti et al. 1999; Lassmann et al. 2001; Lassmann 2004 ). The first 2 patterns are macrophagemediated and antibody-mediated, respectively. Thus, they closely resemble the pattern that is expected for the autoimmune aspect of the disease, for which EAE appears to be an appropriate model. There is currently no known animal model for the third or fourth lesion types, respectively characterized by distal oligodendroglialopathy, and primary oligodendrocyte damage with secondary demyelination.
Here, as a model for demyelinating disease, we used the ND4 mouse line (Mastronardi et al. 1993) , in which the MBP is (on average) less cationic than in the CD1 control (Mastronardi et al. 1996b (Mastronardi et al. , 1996c . This model is based on a genetic lesion, unlike EAE, which is induced by injection of exogenous material (Mastronardi et al. 1996b ). The overexpression of PLP or DM20 can have a variety of consequences, depending on copy number (Kagawa et al. 1994; Mastronardi et al. 1996a ; Wight and Dobretsova 2004; Comparison of the percentage distribution of specific proteins between the supernatant and pellet fractions in 2.0, 5.8, 7.7, and 13 month-old CD1 and ND4 mice (Fig. 4) . The distribution of MAG, CNP, and actin between the supernatant and pellet fractions was approximately equal and similar for all ages. In analyses for MBP, exII-MBP, and p-MBP, all isoforms in the supernatant and in the pellet were summed together. In younger mice (2.0 and 5.8 months), both control and transgenic, higher levels of MBP (*60%) were found in the supernatant compared with the pellet fraction, whereas in older mice (7.7 and 13 months), the distribution was approximately equal. These changes in distribution were also observed for p-MBP. In contrast, exII-MBP was found in higher levels (*60%) in the pellet of young mice and lower levels (*30%) in the pellet of older mice. Differences between CD1 control and ND4 transgenic mice were found upon comparison of the individual MBP isoforms (see text). Error bars represent standard deviations of duplicate or triplicate measurements, when available. Blue, CD1 control; red, ND4 transgenic; open bars, supernatant; filled bars, pellet. Fig. 6 . Isolation of lipid rafts (DRMs, detergent-resistant membranes) from mouse CNS myelin. To isolate DRMs, myelin was lysed at 4 8C for 30 min in 1.5% CHAPS buffer containing protease and phosphatase inhibitors. The CHAPS lysate was centrifuged at low speed. The supernatant was adjusted to 40% sucrose overlaid with 30% sucrose, and finally, overlaid with a 5% sucrose layer. Samples were ultracentrifuged and then fractionated by displacement (Fig. 1) . Fraction 1 contained the lowest concentration of sucrose (5%), and fraction 13 contained the highest (40%). Typically, DRMs are in low-buoyant density fractions 4-6; the slight shift in fraction number was due to the manual start of the fraction collector. Blots were probed with anti-MAG (1:3000), anti-CNP (1:2000), anti-MBP (1:2000), and anti-phosphoThr98 MBP (1:1000). MAG, CNP, and MBP were found in DRMs (low-density fractions), as well as in high-density fractions. In the case of the phosphoThr-MBP blots, none was detected in any of the fractions from young CD1 mice, and this variant was found only in the highdensity fractions of the young ND4 mice (all 2 months of age). In the older mice (13 months), phosphoThr-MBP was clearly detectable in both the DRMs (marked with ovals) and high-density fractions of ND4 mice, but only weakly in the CD1 mice. In all comparisons between CD1 and ND4 mice at a given age, blots were completed simultaneously. Rosenbluth et al. 2006) . We are currently investigating how closely this model resembles the lesions in types 3 and 4 of MS. Nonetheless, this model is useful because the demyelination process is spontaneous, with concomitant MBP posttranslational modifications akin to those in human MS patients, namely, increased overall deimination, and decreased overall phosphorylation (Kim et al. 2003; Mastronardi and Moscarello 2005) .
The ND4 mice have previously been reported to exhibit clinical signs of demyelination beginning at 3 months of age, with progressive worsening until death by 10-12 months (Mastronardi et al. 1993) . We found that clinical and morphological signs of disease were not as marked at young ages, and that most mice could live beyond 12 months of age (Fig. 2) . Some mice lived as long as 18 months, but the clinical signs were severe and required humane euthanasia. This difference may due to greater environmental enrichment in the new facility, which may slow the onset of clinical signs (Arnaiz et al. 2004; Li and Tang 2005; Fields 2005 ). Moreover, we observed a difference in the severity of clinical signs between males and females in the earlier stages (at 7-9 months of age) of the disease that had not hitherto been noted in prior studies in which gender data were either pooled, or only females were examined. Age and gender differences in neurological tests have previously been described in various mouse strains (Bouwknecht and Paylor 2002) . Gender differences have also previously been reported in mouse models of neurological diseases (Dasgupta et al. 2005) . Recently, it has been discovered that CNS myelin turnover is greater in females than in males (Cerghet et al. 2006 ). This sexual dimorphism of oligodendrocyte lifespan may also partially explain the sexual differences in the degree of demyelination observed in ND4 mice. Here, myelin preparations from male and female mice were never pooled; all comparisons shown herein are between females only, or between males only. Fig. 7 . Total protein analysis of sucrose density gradient fractions from lipid raft (DRMs, detergent-resistent membranes) isolation from mouse myelin. (A) The protein content of each fraction was determined by the bicinchoninic acid (BCA) protein assay (Pierce Biotechnology, Rockford). Blue, CD1 control; red, ND4 transgenics. (B) Gradient fractions (1-13) were separated by SDS-PAGE on 14% gels and silver stained. The molecular mass markers (Precision Plus, Bio-Rad) were applied to the lane to the left of fraction 1. In the transgenic mice (ND4), there were at least 3 bands at *17-25 kDa (in marked rectangles) in the DRM fractions, but only 1 prominent band for the CD1 mice (control, negative). In general, there were more bands in the 30-70 kDa range (in marked ovals), in older than in younger mice, of both genotypes.
MBP and microdomains during demyelination
Myelin basic protein comprises a series of splice isoforms whose expression is developmentally and spatially regulated (Campagnoni et al. 1993; Nakajima et al. 1993; Landry et al. 1996; Campagnoni and Campagnoni 2004; Jacobs et al. 2005) . These isoforms are further post-translationally modified, also with a developmental and spatial pattern (Kim et al. 2003; Harauz et al. 2004; Boggs 2006) . It has been suggested that the various post-translational modifications target individual MBPs to different intracellular locations (Zand et al. 1998) , and it was later demonstrated that different charge components of bovine 18.5 kDa MBP interacted differently with model membranes in terms of their association rate coefficient, adhesion, conformation, and clustering tendency (Shanshiashvili et al. 2003) .
Myelin has a unique cytoarchitecture that is further diversified by membrane microdomains (Taylor et al. 2002; Trapp and Kidd 2004; DeBruin and Harauz 2006; Gielen et al. 2006) . In CNS myelin, differential detergent extraction procedures have long been used to isolate MBP in lipidbound form (Riccio et al. 1983 (Riccio et al. , 1984 , substructures such as the radial component (Quarles 1980; Kosaras and Kirschner 1990) , and more recently, to yield other distinct microdomains, including lipid rafts (Simons et al. 2000; Taylor et al. 2002; DeBruin et al. 2005; Arvanitis et al. 2005) . Cultured oligodendrocytes also appear to have different functional domains (Szuchet et al. 1988) , and intriguingly, even different pH microdomains (Ro and Carson 2004) . Lipid rafts may be involved in membrane trafficking (Krämer et al. 2001 ) and growth factor signalling (Baron et al. 2003 (Baron et al. , 2005 Decker et al. 2004) in oligodendrocytes. Myelin membrane microdomains, including lipid rafts and caveolae, have recently been reviewed (DeBruin and Harauz 2006; Gielen et al. 2006) .
The technique of cold detergent extraction, followed by density centrifugation, is a means to isolate DRMs that represent coalesced lipid rafts (Radeva and Sharom 2004) . Under some conditions, lipid rafts and other microdomains, as well as membrane vesicles, are simultaneously isolated. Co-isolation of membrane vesicles is especially problematic with myelin since its lipid-to-protein weight ratio is about 70:30, compared with most plasma membranes, which are composed of approximately equal amounts of lipids and proteins. In general, the protein and lipid composition of the specific microdomain dictate the type of detergent, and the detergent concentration required to isolate it (Schuck et al. 2003; Pike 2004; Lichtenberg et al. 2005 ). In our procedure (Fig. 1) , a low speed centrifugation step is employed, following the cold CHAPS extraction. At this low centrifugal force, the glycosphingolipid-and cholesterol-enriched DRMs remain in the supernatant fraction. The detergentsolubilized proteins and lipids are also in this fraction. The pellet contains subcellular organelles and large myelin fragments that may contain other membrane microdomains. Indeed, we have found that the protein caveolin-1 is predominantly distributed to the pellet fraction after CHAPS lysis of myelin (P1 in Fig. 1 
Partitioning of MBP variants into myelin membrane microdomains
The distribution of the various proteins into the supernatant and pellet fractions (Figs. 4 and 5) gave an initial characterization of their general localization in various membrane microdomains. For example, methylated MBP (20.2 kDa isoform) was only found in the pellet fraction of all mouse myelin samples, regardless of age and disease state. Since it was not partitioned into the supernatant fraction, the methylated MBP could not be found in DRMs; it is a nonraft protein, but may be associated with another type of microdomain in the myelin membrane. In contrast, a significant change in the distribution of exII-MBP isoforms from the pellet to the supernatant fractions occurred with aging. The methylation of MBP (at Arg104 in 18.5 kDa murine MBP) is correlated with compact myelin, and stabilizes the protein's structure and protects it from proteolysis (Chanderkar et al. 1986; Kim et al. 1988; Rawal et al. 1992; Pritzker et al. 2000) . During myelination, exII-MBPs are translocated into the nucleus, where they may have a regulatory role (Pedraza et al. 1997) .
It has been demonstrated that CHAPS-isolated DRMs from myelin, which represent specific lipid rafts, are developmentally regulated (Krämer et al. 1997; Simons et al. 2000) . We have also shown that, although MBP is localized to lipid rafts during the latter stages of bovine myelin development, the phosphoThr-MBP form is only sequestered into the rafts in mature myelin (DeBruin et al. 2005) . Here, we have indications that the localization of MBP, specifically phosphoThr-MBP, into lipid rafts is altered in the spontaneously demyelinating ND4 transgenic mouse line (Fig. 6) . The total levels of all forms of phosphorylated MBP (modified on both seryl and threonyl residues) have previously been reported to be decreased in MS and in ND4 mice (Kim et al. 2003; Mastronardi and Moscarello 2005) . Our data suggest a microdomain redistribution of a specifically modified form of phosphorylated MBP (on Thr95, murine 18.5 kDa sequence numbering) during the demyelination process.
The level of phosphorylation of MBP is dynamic: it is altered during development and maturation, and in MS (Ulmer and Braun 1983; Eichberg and Iyer 1996; Stariha et al. 1997; Kim 2001a, 2001b; Kim et al. 2003) . The threonyl residue within the segment PRTP (human Thr98, bovine Thr97, murine Thr95) is a MAP and GSK-3 kinase site. The phosphorylation of this residue is regulated by action potential generation in axons (Atkins et al. 1999) . The exon-II-containing phosphoMBPs appear to be involved in myelinogenesis (Vartanian et al. 1986) , and the exon-IIlacking phosphoMBPs appear to be involved in myelin maintenance (Campagnoni 1988; Dyer 2002) . Thus, although we see an increased localization of phosphoThr-MBP into DRMs, this observation may be indicative of attempts at remyelination (e.g.,, Capello et al. 1997; Jimenez et al. 2005) . The increased level of phosphorylated MBP in the lipid rafts may be a result of increased targeting into the raft, or potentially hyperphosphorylation of MBP within the raft, which remains to be determined.
The pathology of several diseases, such as Alzheimer's, Niemann-Pick type C1, and amyotrophic lateral sclerosis, are marked by aberrant kinases and hyperphosphorylated substrates (Krieger et al. 2003; Saito et al. 2004; Griffin et al. 2005) . Identification of aberrant kinase activity or phosphorylation may lead to therapeutic treatments for these neuropathies. Abnormal tau hyperphosphorylation and motor deficits were reduced in transgenic mice treated with a kinase inhibitor (Le Corre et al. 2006 ). Our present study highlights the need for further proteomic analyses, and specifically of MBP phosphorylation during demyelination, to define the patterns of modification, the degree of modification (potential hyperphosphorylation), and changes in myelin microdomain partitioning.
Concluding remarks
The classic MBP isoforms are a diverse family of conformationally adaptive proteins that, in addition to passive structural roles in CNS myelin, also act as hubs linking the myelin membrane to several other (including cytoskeletal) proteins. Thus, different forms of the protein would be expected to be targeted to different microdomains within the myelin sheath. Here, we have begun to decipher the altered raft-association of MBP isoforms during in vivo disease, in a spontaneously demyelinating transgenic mouse line, by biochemical dissection using CHAPS detergent. Overall, our results indicate that phosphorylation of MBP at Thr95 (murine 18.5 kDa numbering), in particular, is important in targeting it to lipid rafts, suggesting a unique role for this post-translationally modified form. Further proteomic characterization of MBP phosphorylation, and its partitioning in the myelin membrane, will help define its role in signalling pathways during myelin development and maintenance, and provide new insights into the mechanisms of myelin destabilization.
